Quick Answer
Curanex Pharmaceuticals Inc reported Shares Outstanding of 28.34 million shares for fiscal year 2025.
Curanex Pharmaceuticals Inc Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 28.34M | +18.1% |
| 2024 | 24.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 28.34M | — | +18.1% |
| June 30, 2025 | 24.00M | — | +0.0% |
| December 31, 2024 | 24.00M | — | — |
- Curanex Pharmaceuticals Inc showed an increase of +18.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, Curanex Pharmaceuticals Inc’s shares outstanding has grown by 18.1% (from 24.00 million shares to 28.34 million shares).
- The most recent figure is from Curanex Pharmaceuticals Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: